Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Scientists test new Drug's brain effects using ketamine

NCT ID NCT03844906

Summary

This early-stage study tested an investigational drug called SAGE-718 in 40 healthy volunteers. Researchers used ketamine to temporarily alter brain activity and measured whether SAGE-718 could affect these changes. The main goals were to check the drug's safety, how the body processes it, and its impact on brain wave patterns.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Sage Investigational Site

    Long Beach, California, 90806, United States

  • Sage Investigational Site

    Berlin, New Jersey, 08009, United States

Conditions

Explore the condition pages connected to this study.